O2-6-2EFFECT of Duloxetine on Painful Chemotherapy-Induced Peripheral Neuropathy (original) (raw)
Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial
Kunihiko Ishitani, Masayoshi Kobune
International Journal of Clinical Oncology, 2015
View PDFchevron_right
Duloxetine for the prevention of oxaliplatin induced peripheral neuropathy: a randomized, placebo-controlled, double-blind clinical trial
Mohaddeseh Azadvari
2021
View PDFchevron_right
Evaluating the Effects of Duloxetine on oxaliplatin Induced Peripheral Neuropathy Prophylaxis in Gastrointestinal Cancer Patients, randomized double-blind placebo controlled clinical Trial
Maria Tavakoli
2020
View PDFchevron_right
Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy
Jiani Wang
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2017
View PDFchevron_right
Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Maryam Lustberg
Clinical Cancer Research, 2019
View PDFchevron_right
Comparative Study of the Effects of Duloxetine and Venlafaxine on Acute Symptomatic Taxane-induced Neuropathy in Breast Cancer Patients: a randomized clinical trial
Farnaz Etesam
Journal of Community Hospital Internal Medicine Perspectives, 2024
View PDFchevron_right
Duloxetine for neuropathic pain based on recent clinical trials
David Fishbain
Current Pain and Headache Reports, 2006
View PDFchevron_right
Duloxetine in the Treatment of Neuropathic Pain
Sahar Swidan
Topics in pain management, 2005
View PDFchevron_right
Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies
Dan Ziegler
Clinical Therapeutics, 2007
View PDFchevron_right
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain
Dan Ziegler
Diabetes/Metabolism Research and Reviews, 2009
View PDFchevron_right
Duloxetine Modulates Vincristine-Induced Painful Neuropathy in Rats
Sawsan Zaitone
Journal of Physiology and Pharmacology Advances, 2014
View PDFchevron_right
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives
Laura Poupon, David Balayssac, Nicolas Kerckhove
Expert Opinion on Drug Safety, 2015
View PDFchevron_right
The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
Abbas alipour
Journal of Research in Medical Sciences, 2018
View PDFchevron_right
Retrospective Chart Review of Duloxetine and Pregabalin in the Treatment of Painful Neuropathy
Mazen Dimachkie
International Journal of Neuroscience, 2011
View PDFchevron_right
Duloxetine for Patients with Diabetic Peripheral Neuropathic Pain: A 6-Month Open-Label Safety Study
Fujun Wang
Pain Medicine, 2006
View PDFchevron_right
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
Yu Chung Li
Brain and Behavior, 2019
View PDFchevron_right
Impact of Disease Characteristics on the Efficacy of Duloxetine in Diabetic Peripheral Neuropathic Pain
Dan Ziegler
Diabetes Care, 2007
View PDFchevron_right
Treatment of patients with diabetic peripheral neuropathic pain in China: a double‐blind randomised trial of duloxetine vs. placebo
HECTOR DUENAS
International Journal of Clinical Practice, 2015
View PDFchevron_right
Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
Maryam Lustberg
Cancers, 2021
View PDFchevron_right
Chemotherapy-induced peripheral neuropathy: review for clinical practice
Karine Marley Captein
View PDFchevron_right
Duloxetine and pregabalin in neuropathic pain of lung cancer patients
Hakan Gul
Brain and behavior, 2020
View PDFchevron_right
New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
luis vitetta
Asia-Pacific Journal of Oncology Nursing, 2016
View PDFchevron_right
Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
Héctor Dueñas
Pain research and treatment, 2012
View PDFchevron_right
Chemotherapy Induced Peripheral Neuropathy: Risk Factors, Pathophysiology, Assessment, and Potential Physical Therapy Interventions
Rose Pignataro
Rehabilitation oncology, 2010
View PDFchevron_right
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Anna Wrzosek
View PDFchevron_right
Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review
David Balayssac, Nicolas Kerckhove
View PDFchevron_right
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy
Yelena Granovsky
Pain, 2012
View PDFchevron_right
Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms
Girolamo Ranieri
International Journal of Molecular Sciences
View PDFchevron_right